Suppr超能文献

使用肠段进行尿流改道和膀胱重建/替代,用于治疗顽固性尿失禁或膀胱切除术后。

Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy.

作者信息

Cody June D, Nabi Ghulam, Dublin Norman, McClinton Samuel, Neal David E, Pickard Robert, Yong Sze M

机构信息

Cochrane Incontinence Review Group, University of Aberdeen, Foresterhill, UK.

出版信息

Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD003306. doi: 10.1002/14651858.CD003306.pub2.

Abstract

BACKGROUND

Surgery performed to improve or replace the function of the diseased urinary bladder has been carried out for over a century. Main reasons for improving or replacing the function of the urinary bladder are bladder cancer, neurogenic bladder dysfunction, detrusor overactivity and chronic inflammatory diseases of the bladder (such as interstitial cystitis, tuberculosis and schistosomiasis). There is still much uncertainty about the best surgical approach. Options available at the present time include: (1) conduit diversion (the creation of various intestinal conduits to the skin) or continent diversion (which includes either a rectal reservoir or continent cutaneous diversion), (2) bladder reconstruction and (3) replacement of the bladder with various intestinal segments.

OBJECTIVES

To determine the best way of improving or replacing the function of the lower urinary tract using intestinal segments when the bladder has to be removed or when it has been rendered useless or dangerous by disease.

SEARCH METHODS

We searched the Cochrane Incontinence Group Specialised Trials Register (searched 28 October 2011), which contains trials identified from the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE and CINAHL, and handsearching of journals and conference proceedings, and the reference lists of relevant articles.

SELECTION CRITERIA

All randomised or quasi-randomised controlled trials of surgery involving transposition of an intestinal segment into the urinary tract.

DATA COLLECTION AND ANALYSIS

Trials were evaluated for appropriateness for inclusion and for risk of bias by the review authors. Three review authors were involved in the data extraction. Data were combined in a meta-analysis when appropriate.

MAIN RESULTS

Five trials met the inclusion criteria with a total of 355 participants. These trials addressed only five of the 14 comparisons pre-specified in the protocol. One trial reported no statistically significant differences in the incidence of upper urinary tract infection, uretero-intestinal stenosis and renal deterioration in the comparison of continent diversion with conduit diversion. The confidence intervals were all wide, however, and did not rule out important clinical differences. In a second trial, there was no reported difference in the incidence of upper urinary tract infection and uretero-intestinal stenosis when conduit diversions were fashioned from either ileum or colon. A meta-analysis of two trials showed no statistically significant difference in daytime or nocturnal incontinence amongst participants who were randomised to ileocolonic/ileocaecal segment bladder replacement compared to an ileal bladder replacement. However, one small trial suggested that bladder replacement using an ileal segment compared to using an ileocolonic segment may be better in terms of lower rates of nocturnal incontinence. There were no differences in the incidence of dilatation of upper tract, daytime urinary incontinence or wound infection using different intestinal segments for bladder replacement. However the data were reported for 'renal units', but not in a form that allowed appropriate patient-based paired analyses. No statistically significant difference was found in the incidence of renal scarring between anti-refluxing versus freely refluxing uretero-intestinal anastomotic techniques in conduit diversions and bladder replacement groups. Again, the outcome data were not reported as paired analysis or in form to carry out paired analysis.

AUTHORS' CONCLUSIONS: The evidence from the included trials was very limited. Only five studies met the inclusion criteria; these were small, of moderate or poor methodological quality, and reported few of the pre-selected outcome measures. This review did not find any evidence that bladder replacement (orthotopic or continent diversion) was better than conduit diversion following cystectomy for cancer. There was no evidence to suggest that bladder reconstruction was better than conduit diversion for benign disease. The clinical significance of data from one small trial suggesting that bladder replacement using an ileal segment compared to using an ileocolonic segment is better in terms of lower rates of nocturnal incontinence is uncertain. The small amount of usable evidence for this review suggests that collaborative multi centre studies should be organised, using random allocation where possible.

摘要

背景

旨在改善或替代患病膀胱功能的手术已开展了一个多世纪。改善或替代膀胱功能的主要原因包括膀胱癌、神经源性膀胱功能障碍、逼尿肌过度活动以及膀胱慢性炎症性疾病(如间质性膀胱炎、结核病和血吸虫病)。关于最佳手术方法仍存在诸多不确定性。目前可用的选择包括:(1)导管改道(创建各种通向皮肤的肠导管)或可控性改道(包括直肠贮尿囊或可控性皮肤改道),(2)膀胱重建,以及(3)用各种肠段替代膀胱。

目的

确定在膀胱必须切除或因疾病而失去功能或存在危险时,使用肠段改善或替代下尿路功能的最佳方法。

检索方法

我们检索了Cochrane尿失禁小组专业试验注册库(检索时间为2011年10月28日),其中包含从Cochrane对照试验中央注册库(CENTRAL)、MEDLINE和CINAHL中识别出的试验,以及对期刊和会议论文集的手工检索,还有相关文章的参考文献列表。

选择标准

所有涉及将肠段转位至尿路的手术的随机或半随机对照试验。

数据收集与分析

综述作者评估试验是否适合纳入以及偏倚风险。三名综述作者参与数据提取。在适当情况下,数据进行荟萃分析。

主要结果

五项试验符合纳入标准,共有355名参与者。这些试验仅涉及方案中预先指定的14项比较中的五项。一项试验报告,在可控性改道与导管改道的比较中,上尿路感染、输尿管肠狭窄和肾功能恶化的发生率无统计学显著差异。然而,置信区间都很宽,并未排除重要的临床差异。在第二项试验中,当导管改道由回肠或结肠制成时,上尿路感染和输尿管肠狭窄的发生率未报告有差异。对两项试验的荟萃分析表明,与回肠膀胱替代术相比,随机分配至回结肠/回盲肠段膀胱替代术的参与者在白天或夜间尿失禁方面无统计学显著差异。然而,一项小型试验表明,就夜间尿失禁发生率较低而言,使用回肠段进行膀胱替代可能比使用回结肠段更好。使用不同肠段进行膀胱替代时,上尿路扩张、白天尿失禁或伤口感染的发生率无差异。然而,数据是以“肾单位”报告的,而非以允许进行适当的基于患者的配对分析的形式。在导管改道和膀胱替代组中,抗反流与自由反流输尿管肠吻合技术在肾瘢痕形成发生率方面未发现统计学显著差异。同样,结果数据未作为配对分析报告,也未以可进行配对分析的形式报告。

作者结论

纳入试验的证据非常有限。仅有五项研究符合纳入标准;这些研究规模小,方法学质量中等或较差,且报告的预先选定结局指标很少。本综述未发现任何证据表明膀胱癌膀胱切除术后膀胱替代(原位或可控性改道)优于导管改道。没有证据表明良性疾病的膀胱重建优于导管改道。一项小型试验的数据表明,就夜间尿失禁发生率较低而言,使用回肠段进行膀胱替代比使用回结肠段更好,但其临床意义尚不确定。本综述可用的少量证据表明,应组织协作性多中心研究,并尽可能采用随机分配。

相似文献

1
Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy.
Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD003306. doi: 10.1002/14651858.CD003306.pub2.
3
Acupuncture for treating overactive bladder in adults.
Cochrane Database Syst Rev. 2022 Sep 23;9(9):CD013519. doi: 10.1002/14651858.CD013519.pub2.
4
Single-incision sling operations for urinary incontinence in women.
Cochrane Database Syst Rev. 2017 Jul 26;7(7):CD008709. doi: 10.1002/14651858.CD008709.pub3.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Pelvic floor muscle training with feedback or biofeedback for urinary incontinence in women.
Cochrane Database Syst Rev. 2025 Mar 11;3(3):CD009252. doi: 10.1002/14651858.CD009252.pub2.
9
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
10
Systemic treatments for metastatic cutaneous melanoma.
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.

引用本文的文献

1
Robotic augmentation enterocystoplasty as a treatment for overactive bladder syndrome: Case report.
Int J Surg Case Rep. 2025 Apr;129:111173. doi: 10.1016/j.ijscr.2025.111173. Epub 2025 Mar 19.
2
Stem cell therapy for bladder regeneration: A comprehensive systematic review.
Regen Ther. 2024 Dec 21;28:191-200. doi: 10.1016/j.reth.2024.12.005. eCollection 2025 Mar.
6
The Role of Pelvic Exenteration in Cervical Cancer: A Review of the Literature.
Cancers (Basel). 2024 Feb 18;16(4):817. doi: 10.3390/cancers16040817.
7
Conduit over conduit reconstruction of retracted and fibrosed ileal conduit in severe abdominal adhesions.
Curr Urol. 2022 Mar;16(1):50-52. doi: 10.1097/CU9.0000000000000073. Epub 2021 Dec 28.
8
Orthotopic bladder substitution: Surgical aspects and optimization of outcomes.
BJUI Compass. 2021 Sep 2;2(6):359-369. doi: 10.1002/bco2.84. eCollection 2021 Nov.
9
Human adipose-derived mesenchymal stem cells accelerate decellularized neobladder regeneration.
Regen Biomater. 2020 Mar;7(2):161-169. doi: 10.1093/rb/rbz049. Epub 2019 Dec 22.
10
Outcomes of right colon continent urinary pouch using standardized reporting methods.
Neurourol Urodyn. 2019 Jun;38(5):1290-1297. doi: 10.1002/nau.23951. Epub 2019 Mar 22.

本文引用的文献

4
Does reflux in orthotopic diversion matter? A randomized prospective comparison of the Studer and T-pouch ileal neobladders.
World J Urol. 2009 Feb;27(1):51-5. doi: 10.1007/s00345-008-0341-5. Epub 2008 Nov 12.
6
Treatment of postoperative ileus after bowel surgery with low-dose intravenous erythromycin.
Urology. 2007 Apr;69(4):611-5. doi: 10.1016/j.urology.2006.12.027.
10
Is orthotopic bladder replacement the new gold standard? Evidence from a systematic review.
J Urol. 2005 Jul;174(1):21-8. doi: 10.1097/01.ju.0000162021.24730.4f.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验